Literature DB >> 9079805

Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts.

H Gahéry-Ségard1, V Juillard, J Gaston, R Lengagne, A Pavirani, P Boulanger, J G Guillet.   

Abstract

This study examines in detail the capsid-specific humoral immune response of BALB/c mice after one single injection of a replication-defective adenovirus. Two routes of immunization, intravenous (i.v.) and intraperitoneal (i.p.), were compared for the response induced against the adenovirus particle and the three major components of the viral capsid, hexon, penton base, and fiber. A single immunization with the replication-defective adenovirus induces a long and persistent humoral response specific for the virus. However, the molecular components of the viral capsid are differentially recognized depending on the route of immunization. The sera from mice immunized i.p. recognized only the hexon protein and a preferential switch to the IgG2a subclass was obtained which remained stable 100 days post-immunization. The sera obtained from mice immunized i.v. gave a more complex response. At the beginning of the response, an isotype bias toward the IgG2a subclass was observed, but the isotype distribution changed during the whole period of the response. Neutralizing activity was maximum 45 days after immunization by both routes, and no activity was detectable after 3 months. However, the i.v. serum displayed a higher neutralizing activity than the i.p. serum. The IgM antiviral antibodies appeared to be an important component of the neutralizing activity, and the two routes of immunization do not induce the same IgG isotypes to neutralize viral infectivity. Extension of these findings to human gene therapy using recombinant adenoviruses may help to characterize the precise viral protein targets of neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9079805     DOI: 10.1002/eji.1830270312

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

1.  Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies.

Authors:  C Goldmann; H Petry; S Frye; O Ast; S Ebitsch; K D Jentsch; F J Kaup; F Weber; C Trebst; T Nisslein; G Hunsmann; T Weber; W Lüke
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 2.  The conundrum between immunological memory to adenovirus and their use as vectors in clinical gene therapy.

Authors:  Matthieu Perreau; E J Kremer
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

3.  In vitro gene transfer using human papillomavirus-like particles.

Authors:  A Touze; P Coursaget
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

Review 4.  Cardiac gene therapy: are we there yet?

Authors:  P N Matkar; H Leong-Poi; K K Singh
Journal:  Gene Ther       Date:  2016-04-29       Impact factor: 5.250

5.  Replication-defective vector based on a chimpanzee adenovirus.

Authors:  S F Farina; G P Gao; Z Q Xiang; J J Rux; R M Burnett; M R Alvira; J Marsh; H C Ertl; J M Wilson
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response.

Authors:  Valérie Molinier-Frenkel; Renée Lengagne; Florence Gaden; Saw-See Hong; Jeannine Choppin; Hanne Gahery-Ségard; Pierre Boulanger; Jean-Gérard Guillet
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice.

Authors:  Christopher Palma; Michael G Overstreet; Jean-Marc Guedon; Egbert Hoiczyk; Cameron Ward; Kasey A Karen; Fidel Zavala; Gary Ketner
Journal:  Vaccine       Date:  2011-01-01       Impact factor: 3.641

8.  Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.

Authors:  B G Harvey; N R Hackett; T El-Sawy; T K Rosengart; E A Hirschowitz; M D Lieberman; M L Lesser; R G Crystal
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Optimizing atoh1-induced vestibular hair cell regeneration.

Authors:  Hinrich Staecker; Christina Schlecker; Shannon Kraft; Mark Praetorius; Chi Hsu; Douglas E Brough
Journal:  Laryngoscope       Date:  2014-06-17       Impact factor: 3.325

10.  Therapeutic effects of recombinant human endostatin adenovirus in a mouse model of malignant pleural effusion.

Authors:  Fang Fang; Ping Chen; Xin Wu; Li Yang; Xun Yang; Zhen-Xiang Xi; Bin-Wen Zhou; Xi-Kun Zhou; Zhi-Yong Qian; Bo Xiao; Yu-Quan Wei
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-15       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.